Brain tests help monitor the progression of Alzheimer's disease

NEW YORK (Reuters Health) – According to a new study, brain tests can improve the diagnosis and treatment of Alzheimer's disease.

The researchers evaluated the use of computed tomography (CT) to detect Alzheimer's amyloid plaques in the brain. The study involved more than 11,000 patients receiving low-risk or low-risk medical care for uncertain reasons.

Brain Analysis Results Altered Treatment of Disease – Including Drug Use and Counseling – in About Two-Thirds of Cases, Study Published in the April Issue of the Journal of the American Medical Association .

"These findings provide highly credible evidence that computerized amyloid imaging can be a powerful tool to improve the diagnostic accuracy of Alzheimer's disease and lead to better medical management, particularly in cases where the Alzheimer's disease is diagnosed, "said Dr. Maria David, MD, professor of Alzheimer's disease. Difficult to diagnose. "" It is important that multiprotocol tomography is more widely available for those who need it. "

The researchers pointed out the lack of treatment for Alzheimer's disease, but early diagnosis means that patients can receive treatment and symptom management, as well as indications about the need for clinical trials to develop new drugs.